Tyrosine kinase inhibitors are promising therapeutic tools for cats with HER2-positive mammary carcinoma
Research Areas: Pharmacology & Pharmacy
Main Author: | |
---|---|
Other Authors: | , , , |
Format: | article |
Language: | eng |
Published: |
2022
|
Subjects: | |
Online Access: | http://hdl.handle.net/10400.5/23406 |
Country: | Portugal |
Oai: | oai:www.repository.utl.pt:10400.5/23406 |
Summary: | Research Areas: Pharmacology & Pharmacy |
---|